Ebola Vaccine Candidate Promising in Early Study

Related posts:

1. Koch tells Health Minister to ‘get a backbone’, resigns from organ donation advisory council Television presenter David Koch resigns as chairman of the Organ and Tissue Authority Advisory Council in protest over the Government's handling of a review into organ donation....
2. Controlling Brain Circuits in Mice Controlling Brain Circuits in Mice Researchers developed a tool that can turn specific sets of neurons on and off in mice to affect behavior. The technology can help scientists study mental health and disorders....
3. New urine test could reduce need for blood samples If you've been to the doctor, you probably know what to do when you're handed a plastic cup and shown to the bathroom....
4. Drugs Lessen Multiple Sclerosis Damage in Mice Drugs Lessen Multiple Sclerosis Damage in MiceIn a mouse study, 2 drugs already on the market activated stem cells and repaired the type of brain damage seen in multiple sclerosis. The finding might lead to novel therapies....
5. Non-Habit Forming Painkiller May Soon Hit The Market Researchers at Stony Brook University have developed a powerful new painkiller that is said to possess no apparent side effects or addictive qualities could be available for purchase within the next year or two. At present, this miracle drug is in Phase II clinical trials in England and Canada.A painkiller or analgesic is any member of the group of drugs used to relieve pain. The term analgesic is derived from Greek “an”, meaning without, and “algos”, meaning pain. These drugs include paracetamol (better known as acetaminophen), non-steroidal anti-inflammatory drugs (NSAIDs), and opioids such as morphine and opium. Commonly prescribed painkillers...